Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy vs Continuous Subcutaneous Insulin Infusion in Patients With Type 1 Diabetes in the Netherlands

ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s186298
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes

JAMA - Journal of the American Medical Association
Medicine
2013English

Consequences of Delayed Pump Infusion Line Change in Patients With Type 1 Diabetes Mellitus Treated With Continuous Subcutaneous Insulin Infusion

Journal of Diabetes and its Complications
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Preconceptional Diabetes Control in Insulin-Dependent Diabetes Mellitus Patients With Continuous Subcutaneous Insulin Infusion Therapy

Journal of Perinatal Medicine
GynecologyChild HealthPediatricsPerinatologyObstetrics
1987English

Clinical and Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion for Diabetes

Health Technology Assessment
MedicineHealth Policy
2004English

Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy

Canadian Journal of Diabetes
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2014English

Vitiligo Associated With Subcutaneous Insulin Lispro Infusion in Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Continuous Subcutaneous Insulin Infusion

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
1997English

Cost-Effectiveness of Continuous Glucose Monitoring and Intensive Insulin Therapy for Type 1 Diabetes

Cost Effectiveness and Resource Allocation
Health Policy
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy